Dr Michael O'reilly & Associates Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2887 S Arlington Rd, Akron, OH 44312 Phone: 330-645-9560 Fax: 330-645-1302 |
Dr. Madeline Curtis, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2282 Newton St, Akron, OH 44305 Phone: 330-794-9700 |
Frances C Flower, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 676 S Broadway St, Akron, OH 44311 Phone: 330-344-2020 Fax: 330-344-4111 |
Dr. Ronald Wacht, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Brittain Rd Ste 10, Akron, OH 44310 Phone: 330-633-3556 |
Wrea Ii Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1558 Akron Peninsula Rd, Akron, OH 44313 Phone: 330-422-9999 Fax: 330-422-0316 |
R Timothy Miller Od Optometrist Medicare: Medicare Enrolled Practice Location: 3235 Manchester Rd, Suite 1, Akron, OH 44319 Phone: 330-644-7138 Fax: 330-643-1990 |
Dr James Farkas And Associates Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Brittain Rd, Suite 601, Akron, OH 44310 Phone: 330-633-4777 Fax: 330-633-4801 |
Dr Robert Murphy Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 863 E Market St, Akron, OH 44305 Phone: 330-376-9377 Fax: 330-376-2999 |
Wayne Robert Evert, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2355 Manchester Rd, Akron, OH 44314 Phone: 330-753-2266 |
The Eye Site At New Seasons Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1485 S Hawkins Ave Ste 130, Akron, OH 44320 Phone: 330-208-9427 Fax: 330-208-9428 |
Northeast Ohio Eye Surgeons, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 4099 Embassy Parkway, Akron, OH 44333 Phone: 330-835-1844 Fax: 330-836-8598 |
Dr. Robert C Bevington, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3235 Manchester Rd, Suite 1, Akron, OH 44319 Phone: 330-644-7138 Fax: 330-645-1990 |
Oic Integrative Optometry Llc Optometrist Medicare: Medicare Enrolled Practice Location: 512 Canton Rd, Akron, OH 44312 Phone: 330-784-1155 |
Jeff Durkin, Od Optometrist - Low Vision Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1655 W Market St, Akron, OH 44313 Phone: 330-867-1104 |
Diana Johns, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55 W Waterloo Rd, Akron, OH 44319 Phone: 330-724-7715 |
Saf Vision Holdings Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Brittain Rd Ste 601, Akron, OH 44310 Phone: 330-633-7129 |
Casandra Sofia Solis, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 |
Dr. Ronald Timothy Miller, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3235 Manchester Rd, Akron, OH 44319 Phone: 330-644-7138 Fax: 330-645-1990 |
Sarah Guillette, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 |
Dr. Jennifer Ann Choate, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 55 W Waterloo Rd, Akron, OH 44319 Phone: 330-724-7715 Fax: 330-724-1029 |
News Archive
The Cancer Prevention and Research Institute of Texas recently presented a $300,000 check to the University of North Texas Health Science Center. The check was accepted by the UNT Health Science Center Provost Thomas Yorio, Ph.D., and Richard Kurz, Ph.D., dean of the School of Public Health.
Using monoclonal antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and senescent markers, researchers provide evidence that virus-infected lung cells acquire characteristics of cellular senescence, which also leads to expression of proinflammatory cytokines.
A few minutes spent filling out a widely accepted mental health assessment in a health care provider's waiting room could make a big difference for some teenagers suffering from depression, according to new study from a nursing researcher at The University of Texas at Arlington.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
› Verified 6 days ago